Insights | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Webinar | May 14, 2020

Global Patent Protection Strategies and Foreign Filing Licenses

Webinar | May 09, 2018

The Two Sides of the Coin in Post-Grant Practice: Petitioner and Patent Owner Estoppel

Webinar | August 09, 2017

Post-Grant for Practitioners: Choosing Whether to Challenge a Patent at the PTAB - Has Shaw Watered Down Petitioner Estoppel?

Webinar | April 05, 2017

IP Perspectives - US and China Webinar Series: Cross-Border Patent Issues in the Life Sciences

Webinar | October 13, 2016

Biologics Litigation and IPRs

Blog | February 02, 2016

Decision on Institution in PGR petition (PGR2015-00019); US Patent 8,876,991

Blog | October 30, 2015

Phigenix v Genentech; Claims Found Not Unpatentable In Final Written Decision

Blog | July 29, 2015

Sanofi Challenges Two Members of "Cabilly" Family of Patents

Blog | May 19, 2015

Life Sciences IPR Final Written Decision; Touches on Written Description, 102 and 103

Webinar | March 31, 2015

Recent Developments in Bio-Pharma

Blog | January 07, 2015

1st-Ever AIA Post-Grant Review Ends In Settlement

Article | May 28, 2009

The Bright Side of Nuclear Winter: Opportunities in the New, New Economy